{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:21Z","timestamp":1787020881607,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014732","name":"Neurofibromatosis Therapy Acceleration Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Epigenetics &amp; Chromatin"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Benign peripheral nerve sheath tumors are the clinical hallmark of Neurofibromatosis Type 1. They account for substantial morbidity and mortality in NF1. Cutaneous (CNF) and plexiform neurofibromas (PNF) share nearly identical histology, but maintain different growth rates and risk of malignant conversion. The reasons for this disparate clinical behavior are not well explained by recent genome or transcriptome profiling studies. We hypothesized that CNFs and PNFs are epigenetically distinct tumor types that exhibit differential signaling due to genome-wide and site-specific methylation events. We interrogated the methylation profiles of 45 CNFs and 17 PNFs from NF1 subjects with the Illumina EPIC 850K methylation array. Based on these profiles, we confirm that CNFs and PNFs are epigenetically distinct tumors with broad differences in higher-order chromatin states and specific methylation events altering genes involved in key biological and cellular processes, such as inflammation, RAS\/MAPK signaling, actin cytoskeleton rearrangement, and oxytocin signaling. Based on our identification of two separate DMRs associated with alternative leading exons in\n                    <jats:italic>MAP2K3,<\/jats:italic>\n                    we demonstrate differential RAS\/MKK3\/p38 signaling between CNFs and PNFs. Epigenetic reinforcement of RAS\/MKK\/p38 was a defining characteristic of CNFs leading to pro-inflammatory signaling and chromatin conformational changes, whereas PNFs signaled predominantly through RAS\/MEK. Tumor size also correlated with specific CpG methylation events. Taken together, these findings confirm that\n                    <jats:italic>NF1<\/jats:italic>\n                    deficiency influences the epigenetic regulation of RAS signaling fates, accounting for observed differences in CNF and PNF clinical behavior. The extension of these findings is that CNFs may respond differently than PNFs to RAS-targeted therapeutics raising the possibility of targeting p38-mediated inflammation for CNF treatment.\n                  <\/jats:p>","DOI":"10.1186\/s13072-020-00380-6","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T20:02:42Z","timestamp":1610481762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK\/p38 signaling"],"prefix":"10.1186","volume":"14","author":[{"given":"Jamie L.","family":"Grit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin K.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Dischinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curt","family":"J. Essenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A.","family":"Pratilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Tim J.","family":"Triche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie R.","family":"Graveel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9003-6730","authenticated-orcid":false,"given":"Matthew R.","family":"Steensma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"380_CR1","doi-asserted-by":"publisher","first-page":"7429697","DOI":"10.1155\/2017\/7429697","volume":"2017","author":"A Kim","year":"2017","unstructured":"Kim A, Stewart DR, Reilly KM, Viskochil D, Miettinen MM, Widemann BC. Malignant peripheral nerve sheath tumors state of the science: leveraging clinical and biological insights into effective therapies. Sarcoma. 2017;2017:7429697.","journal-title":"Sarcoma"},{"issue":"4","key":"380_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10048-010-0240-y","volume":"11","author":"L Thomas","year":"2010","unstructured":"Thomas L, Kluwe L, Chuzhanova N, Mautner V, Upadhyaya M. Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden. Neurogenetics. 2010;11(4):391\u2013400.","journal-title":"Neurogenetics"},{"issue":"6","key":"380_CR3","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1186\/1479-7364-5-6-623","volume":"5","author":"S Laycock-van Spyk","year":"2011","unstructured":"Laycock-van Spyk S, Thomas N, Cooper DN, Upadhyaya M. Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis. Hum Genomics. 2011;5(6):623\u201390.","journal-title":"Hum Genomics"},{"issue":"1","key":"380_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13023-018-0772-z","volume":"13","author":"A Cannon","year":"2018","unstructured":"Cannon A, Chen MJ, Li P, Boyd KP, Theos A, Redden DT, Korf B. Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study. Orphanet J Rare Dis. 2018;13(1):31.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"380_CR5","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/emmm.200900027","volume":"1","author":"SJ Miller","year":"2009","unstructured":"Miller SJ, Jessen WJ, Mehta T, Hardiman A, Sites E, Kaiser S, Jegga AG, Li H, Upadhyaya M, Giovannini M, et al. Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. EMBO Mol Med. 2009;1(4):236\u201348.","journal-title":"EMBO Mol Med"},{"issue":"2","key":"380_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.gene.2014.12.064","volume":"558","author":"A Asai","year":"2015","unstructured":"Asai A, Karnan S, Ota A, Takahashi M, Damdindorj L, Konishi Y, Hossain E, Konishi H, Nagata A, Yokoo K, et al. High-resolution 400K oligonucleotide array comparative genomic hybridization analysis of neurofibromatosis type 1-associated cutaneous neurofibromas. Gene. 2015;558(2):220\u20136.","journal-title":"Gene"},{"issue":"3","key":"380_CR7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1750-3639.2004.tb00062.x","volume":"14","author":"N Holtkamp","year":"2004","unstructured":"Holtkamp N, Reuss DE, Atallah I, Kuban RJ, Hartmann C, Mautner VF, Frahm S, Friedrich RE, Algermissen B, Pham VA, et al. Subclassification of nerve sheath tumors by gene expression profiling. Brain Pathol. 2004;14(3):258\u201364.","journal-title":"Brain Pathol"},{"issue":"5","key":"380_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.stem.2009.03.017","volume":"4","author":"LQ Le","year":"2009","unstructured":"Le LQ, Shipman T, Burns DK, Parada LF. Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas. Cell Stem Cell. 2009;4(5):453\u201363.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"380_CR9","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ccell.2014.09.009","volume":"26","author":"Z Chen","year":"2014","unstructured":"Chen Z, Liu C, Patel AJ, Liao CP, Wang Y, Le LQ. Cells of origin in the embryonic nerve roots for NF1-associated plexiform neurofibroma. Cancer Cell. 2014;26(5):695\u2013706.","journal-title":"Cancer Cell"},{"issue":"2","key":"380_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1182\/blood-2009-09-242875","volume":"116","author":"K Staser","year":"2010","unstructured":"Staser K, Yang FC, Clapp DW. Mast cells and the neurofibroma microenvironment. Blood. 2010;116(2):157\u201364.","journal-title":"Blood"},{"issue":"3","key":"380_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cell.2008.08.041","volume":"135","author":"FC Yang","year":"2008","unstructured":"Yang FC, Ingram DA, Chen S, Zhu Y, Yuan J, Li X, Yang X, Knowles S, Horn W, Li Y, et al. Nf1-dependent tumors require a microenvironment containing Nf1+\/\u2013 and c-kit-dependent bone marrow. Cell. 2008;135(3):437\u201348.","journal-title":"Cell"},{"issue":"18","key":"380_CR12","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1016\/j.ejca.2004.07.021","volume":"40","author":"A Harder","year":"2004","unstructured":"Harder A, Rosche M, Reuss DE, Holtkamp N, Uhlmann K, Friedrich R, Mautner VF, von Deimling A. Methylation analysis of the neurofibromatosis type 1 (NF1) promoter in peripheral nerve sheath tumours. Eur J Cancer. 2004;40(18):2820\u20138.","journal-title":"Eur J Cancer"},{"issue":"6","key":"380_CR13","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00401-016-1540-6","volume":"131","author":"M Rohrich","year":"2016","unstructured":"Rohrich M, Koelsche C, Schrimpf D, Capper D, Sahm F, Kratz A, Reuss J, Hovestadt V, Jones DT, Bewerunge-Hudler M, et al. Methylation-based classification of benign and malignant peripheral nerve sheath tumors. Acta Neuropathol. 2016;131(6):877\u201387.","journal-title":"Acta Neuropathol"},{"issue":"2 Suppl 1","key":"380_CR14","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1212\/WNL.0000000000005792","volume":"91","author":"N Ortonne","year":"2018","unstructured":"Ortonne N, Wolkenstein P, Blakeley JO, Korf B, Plotkin SR, Riccardi VM, Miller DC, Huson S, Peltonen J, Rosenberg A, et al. Cutaneous neurofibromas: current clinical and pathologic issues. Neurology. 2018;91(2 Suppl 1):S5\u201313.","journal-title":"Neurology"},{"issue":"1","key":"380_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/2045-3329-2-17","volume":"2","author":"DG Evans","year":"2012","unstructured":"Evans DG, Huson SM, Birch JM. Malignant peripheral nerve sheath tumours in inherited disease. Clin Sarcoma Res. 2012;2(1):17.","journal-title":"Clin Sarcoma Res"},{"issue":"10","key":"380_CR16","first-page":"170045","volume":"4","author":"K Pollard","year":"2019","unstructured":"Pollard K, Banerjee J, Doan X, Wang J, Guo X, Allaway R, Langmead S, Slobogean B, Meyer CF, Loeb DM, et al. A clinically and genomically annotated nerve sheath tumor biospecimen repository. bioRxiv. 2019;4(10):170045.","journal-title":"bioRxiv"},{"issue":"4","key":"380_CR17","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1158\/1078-0432.CCR-07-1305","volume":"14","author":"KK Mantripragada","year":"2008","unstructured":"Mantripragada KK, Spurlock G, Kluwe L, Chuzhanova N, Ferner RE, Frayling IM, Dumanski JP, Guha A, Mautner V, Upadhyaya M. High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization. Clin Cancer Res. 2008;14(4):1015\u201324.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"380_CR18","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1101\/gr.101907.109","volume":"20","author":"L Laurent","year":"2010","unstructured":"Laurent L, Wong E, Li G, Huynh T, Tsirigos A, Ong CT, Low HM, Kin Sung KW, Rigoutsos I, Loring J, et al. Dynamic changes in the human methylome during differentiation. Genome Res. 2010;20(3):320\u201331.","journal-title":"Genome Res"},{"issue":"12","key":"380_CR19","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/ng.471","volume":"41","author":"A Doi","year":"2009","unstructured":"Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, Herb B, Ladd-Acosta C, Rho J, Loewer S, et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet. 2009;41(12):1350\u20133.","journal-title":"Nat Genet"},{"issue":"14","key":"380_CR20","doi-asserted-by":"publisher","first-page":"6816","DOI":"10.1093\/nar\/gkt482","volume":"41","author":"ND Vanderkraats","year":"2013","unstructured":"Vanderkraats ND, Hiken JF, Decker KF, Edwards JR. Discovering high-resolution patterns of differential DNA methylation that correlate with gene expression changes. Nucleic Acids Res. 2013;41(14):6816\u201327.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"380_CR21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41588-018-0073-4","volume":"50","author":"W Zhou","year":"2018","unstructured":"Zhou W, Dinh HQ, Ramjan Z, Weisenberger DJ, Nicolet CM, Shen H, Laird PW, Berman BP. DNA methylation loss in late-replicating domains is linked to mitotic cell division. Nat Genet. 2018;50(4):591\u2013602.","journal-title":"Nat Genet"},{"issue":"10","key":"380_CR22","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1182\/blood-2017-09-803809","volume":"131","author":"W Sun","year":"2018","unstructured":"Sun W, Triche T Jr, Malvar J, Gaynon P, Sposto R, Yang X, Bittencourt H, Place AE, Messinger Y, Fraser C, et al. A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from the TACL consortium. Blood. 2018;131(10):1145\u20138.","journal-title":"Blood"},{"issue":"5950","key":"380_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1126\/science.1181369","volume":"326","author":"E Lieberman-Aiden","year":"2009","unstructured":"Lieberman-Aiden E, van Berkum NL, Williams L, Imakaev M, Ragoczy T, Telling A, Amit I, Lajoie BR, Sabo PJ, Dorschner MO, et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science. 2009;326(5950):289\u201393.","journal-title":"Science"},{"issue":"7539","key":"380_CR24","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nature14222","volume":"518","author":"JR Dixon","year":"2015","unstructured":"Dixon JR, Jung I, Selvaraj S, Shen Y, Antosiewicz-Bourget JE, Lee AY, Ye Z, Kim A, Rajagopal N, Xie W, et al. Chromatin architecture reorganization during stem cell differentiation. Nature. 2015;518(7539):331\u20136.","journal-title":"Nature"},{"issue":"1","key":"380_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.stemcr.2019.05.021","volume":"13","author":"V Dileep","year":"2019","unstructured":"Dileep V, Wilson KA, Marchal C, Lyu X, Zhao PA, Li B, Poulet A, Bartlett DA, Rivera-Mulia JC, Qin ZS, et al. Rapid irreversible transcriptional reprogramming in human stem cells accompanied by discordance between replication timing and chromatin compartment. Stem Cell Rep. 2019;13(1):193\u2013206.","journal-title":"Stem Cell Rep"},{"issue":"47","key":"380_CR26","doi-asserted-by":"publisher","first-page":"E6456","DOI":"10.1073\/pnas.1518552112","volume":"112","author":"AL Sanborn","year":"2015","unstructured":"Sanborn AL, Rao SS, Huang SC, Durand NC, Huntley MH, Jewett AI, Bochkov ID, Chinnappan D, Cutkosky A, Li J, et al. Chromatin extrusion explains key features of loop and domain formation in wild-type and engineered genomes. Proc Natl Acad Sci USA. 2015;112(47):E6456-6465.","journal-title":"Proc Natl Acad Sci USA"},{"key":"380_CR27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13059-015-0741-y","volume":"16","author":"JP Fortin","year":"2015","unstructured":"Fortin JP, Hansen KD. Reconstructing A\/B compartments as revealed by Hi-C using long-range correlations in epigenetic data. Genome Biol. 2015;16:180.","journal-title":"Genome Biol"},{"issue":"3","key":"380_CR28","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/ajmg.a.33851","volume":"155A","author":"MB Rieley","year":"2011","unstructured":"Rieley MB, Stevenson DA, Viskochil DH, Tinkle BT, Martin LJ, Schorry EK. Variable expression of neurofibromatosis 1 in monozygotic twins. Am J Med Genet A. 2011;155A(3):478\u201385.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"380_CR29","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.neuroscience.2009.05.008","volume":"162","author":"LS Sorkin","year":"2009","unstructured":"Sorkin LS, Boyle DL, Hammaker D, Herman DS, Vail E, Firestein GS. MKK3, an upstream activator of p38, contributes to formalin phase 2 and late allodynia in mice. Neuroscience. 2009;162(2):462\u201371.","journal-title":"Neuroscience"},{"issue":"6508","key":"380_CR30","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/372739a0","volume":"372","author":"JC Lee","year":"1994","unstructured":"Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 1994;372(6508):739\u201346.","journal-title":"Nature"},{"issue":"8","key":"380_CR31","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1002\/j.1460-2075.1996.tb00542.x","volume":"15","author":"R Beyaert","year":"1996","unstructured":"Beyaert R, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, Cohen P, Fiers W. The p38\/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 1996;15(8):1914\u201323.","journal-title":"EMBO J"},{"issue":"3","key":"380_CR32","doi-asserted-by":"publisher","first-page":"eaau7566","DOI":"10.1126\/sciadv.aau7566","volume":"5","author":"W Li","year":"2019","unstructured":"Li W, Wang HY, Zhao X, Duan H, Cheng B, Liu Y, Zhao M, Shu W, Mei Y, Wen Z, et al. A methylation-phosphorylation switch determines Plk1 kinase activity and function in DNA damage repair. Sci Adv. 2019;5(3):eaau7566.","journal-title":"Sci Adv"},{"issue":"16","key":"380_CR33","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1101\/gad.1107303","volume":"17","author":"D Brancho","year":"2003","unstructured":"Brancho D, Tanaka N, Jaeschke A, Ventura JJ, Kelkar N, Tanaka Y, Kyuuma M, Takeshita T, Flavell RA, Davis RJ. Mechanism of p38 MAP kinase activation in vivo. Genes Dev. 2003;17(16):1969\u201378.","journal-title":"Genes Dev"},{"issue":"50","key":"380_CR34","doi-asserted-by":"publisher","first-page":"38973","DOI":"10.1074\/jbc.M002856200","volume":"275","author":"G Chen","year":"2000","unstructured":"Chen G, Hitomi M, Han J, Stacey DW. The p38 pathway provides negative feedback for Ras proliferative signaling. J Biol Chem. 2000;275(50):38973\u201380.","journal-title":"J Biol Chem"},{"issue":"26","key":"380_CR35","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","volume":"375","author":"E Dombi","year":"2016","unstructured":"Dombi E, Baldwin A, Marcus LJ, Fisher MJ, Weiss B, Kim A, Whitcomb P, Martin S, Aschbacher-Smith LE, Rizvi TA, et al. Activity of selumetinib in neurofibromatosis type 1-related plexiform neurofibromas. N Engl J Med. 2016;375(26):2550\u201360.","journal-title":"N Engl J Med"},{"issue":"22","key":"380_CR36","doi-asserted-by":"publisher","first-page":"6626","DOI":"10.1158\/1078-0432.CCR-06-0467","volume":"12","author":"PS Yan","year":"2006","unstructured":"Yan PS, Venkataramu C, Ibrahim A, Liu JC, Shen RZ, Diaz NM, Centeno B, Weber F, Leu YW, Shapiro CL, et al. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Clin Cancer Res. 2006;12(22):6626\u201336.","journal-title":"Clin Cancer Res"},{"issue":"18","key":"380_CR37","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/jnci\/dji275","volume":"97","author":"L Shen","year":"2005","unstructured":"Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR, Einspahr JG, et al. MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst. 2005;97(18):1330\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"380_CR38","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1158\/0008-5472.CAN-09-0028","volume":"69","author":"Z Jin","year":"2009","unstructured":"Jin Z, Cheng Y, Gu W, Zheng Y, Sato F, Mori Y, Olaru AV, Paun BC, Yang J, Kan T, et al. A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett\u2019s esophagus. Cancer Res. 2009;69(10):4112\u20135.","journal-title":"Cancer Res"},{"issue":"5","key":"380_CR39","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1053\/jhep.2000.19797","volume":"32","author":"Y Kondo","year":"2000","unstructured":"Kondo Y, Kanai Y, Sakamoto M, Mizokami M, Ueda R, Hirohashi S. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis\u2013a comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology. 2000;32(5):970\u20139.","journal-title":"Hepatology"},{"issue":"12","key":"380_CR40","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1158\/1940-6207.CAPR-11-0096","volume":"4","author":"YC Lee","year":"2011","unstructured":"Lee YC, Wang HP, Wang CP, Ko JY, Lee JM, Chiu HM, Lin JT, Yamashita S, Oka D, Watanabe N, et al. Revisit of field cancerization in squamous cell carcinoma of upper aerodigestive tract: better risk assessment with epigenetic markers. Cancer Prev Res (Phila). 2011;4(12):1982\u201392.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"380_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4161\/epi.3.1.5469","volume":"3","author":"RG Tuskan","year":"2008","unstructured":"Tuskan RG, Tsang S, Sun Z, Baer J, Rozenblum E, Wu X, Munroe DJ, Reilly KM. Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levels. Epigenetics. 2008;3(1):43\u201350.","journal-title":"Epigenetics"},{"issue":"1\u20133","key":"380_CR42","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1006\/geno.2001.6607","volume":"76","author":"T Imamura","year":"2001","unstructured":"Imamura T, Ohgane J, Ito S, Ogawa T, Hattori N, Tanaka S, Shiota K. CpG island of rat sphingosine kinase-1 gene: tissue-dependent DNA methylation status and multiple alternative first exons. Genomics. 2001;76(1\u20133):117\u201325.","journal-title":"Genomics"},{"key":"380_CR43","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1186\/s12885-015-1718-7","volume":"15","author":"K Matula","year":"2015","unstructured":"Matula K, Collie-Duguid E, Murray G, Parikh K, Grabsch H, Tan P, Lalwani S, Garau R, Ong Y, Bain G, et al. Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phosphate lyase determines chemotherapy resistance in gastroesophageal cancer. BMC Cancer. 2015;15:762.","journal-title":"BMC Cancer"},{"issue":"17","key":"380_CR44","doi-asserted-by":"publisher","first-page":"14884","DOI":"10.1074\/jbc.M111718200","volume":"277","author":"YQ Xiao","year":"2002","unstructured":"Xiao YQ, Malcolm K, Worthen GS, Gardai S, Schiemann WP, Fadok VA, Bratton DL, Henson PM. Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-beta. J Biol Chem. 2002;277(17):14884\u201393.","journal-title":"J Biol Chem"},{"issue":"1","key":"380_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jpain.2004.10.001","volume":"6","author":"SW Ko","year":"2005","unstructured":"Ko SW, Vadakkan KI, Ao H, Gallitano-Mendel A, Wei F, Milbrandt J, Zhuo M. Selective contribution of Egr1 (zif\/268) to persistent inflammatory pain. J Pain. 2005;6(1):12\u201320.","journal-title":"J Pain"},{"issue":"2\u20133","key":"380_CR46","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.pbiomolbio.2010.05.001","volume":"102","author":"L Tang","year":"2010","unstructured":"Tang L, Nogales E, Ciferri C. Structure and function of SWI\/SNF chromatin remodeling complexes and mechanistic implications for transcription. Prog Biophys Mol Biol. 2010;102(2\u20133):122\u20138.","journal-title":"Prog Biophys Mol Biol"},{"issue":"7","key":"380_CR47","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/ng1378","volume":"36","author":"C Simone","year":"2004","unstructured":"Simone C, Forcales SV, Hill DA, Imbalzano AN, Latella L, Puri PL. p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat Genet. 2004;36(7):738\u201343.","journal-title":"Nat Genet"},{"issue":"4","key":"380_CR48","first-page":"e22","volume":"45","author":"W Zhou","year":"2017","unstructured":"Zhou W, Laird PW, Shen H. Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes. Nucleic Acids Res. 2017;45(4):e22.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"380_CR49","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/bioinformatics\/btw691","volume":"33","author":"JP Fortin","year":"2017","unstructured":"Fortin JP, Triche TJ Jr, Hansen KD. Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi. Bioinformatics. 2017;33(4):558\u201360.","journal-title":"Bioinformatics"},{"issue":"20","key":"380_CR50","first-page":"e123","volume":"46","author":"W Zhou","year":"2018","unstructured":"Zhou W, Triche TJ Jr, Laird PW, Shen H. SeSAMe: reducing artifactual detection of DNA methylation by Infinium BeadChips in genomic deletions. Nucleic Acids Res. 2018;46(20):e123.","journal-title":"Nucleic Acids Res"}],"container-title":["Epigenetics &amp; Chromatin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-020-00380-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13072-020-00380-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13072-020-00380-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T09:09:49Z","timestamp":1697533789000},"score":1,"resource":{"primary":{"URL":"https:\/\/epigeneticsandchromatin.biomedcentral.com\/articles\/10.1186\/s13072-020-00380-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["380"],"URL":"https:\/\/doi.org\/10.1186\/s13072-020-00380-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-78134\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.1101\/833467","asserted-by":"object"}]},"ISSN":["1756-8935"],"issn-type":[{"value":"1756-8935","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"14 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None of the authors have any competing interest disclosures. None of the authors have any competing financial or non-financial interests to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7"}}